Clinical Trial Update: Trial of Buprenorphine/Naloxone for Opiate Dependence - 2 [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 clinical trial evaluating buprenorphine/naloxone for opioid use disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Buprenorphine/naloxone (buprenorphine/naloxone)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Opioid-Related Disorders, Substance-Related Disorders | Phase 2 | Status: COMPLETED